BioTryp Therapeutics Analysis
What is BioTryp Therapeutics?
Antibiofilm therapy targeting UTIs and biofilm-related infections
Location
Cambridge, United Kingdom
Employees
1-10
Founded
2023
Product Features & Capabilities
- Small molecules inhibiting biofilm formation
- Non-antibiotic therapy for UTIs
- Antibiofilm technology targeting bladder wall and catheter biofilms
Use Cases
Treat UTIs in women and men with biofilm-related infections; Prevent recurrent UTIs in high-risk patients; Address hospital-acquired bloodstream infections linked to biofilms; Reduce antibiotic use in catheter-associated infections
Other Considerations
Founded in 2023; Based in Cambridge, UK; Supported by Cambridge University, Santander X, ICURe HD, NBIC, Spin Up Ventures, Empirical Ventures, Innovate UK; First indication in urinary tract infections
